Arch Venture Fund Viii Overage, L.p. - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Codiak BioSciences Inc (CDAKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Codiak BioSciences Inc (CDAKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Codiak BioSciences Inc (CDAKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Viii Overage, L.p. made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 1,952 shares made by Julie Jordan , a net sale of 13,037 shares made by Arthur Tzianabos , and a net sale of 7,280 shares made by Paul Alloway .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,413 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Viii Overage, L.p. made no insider transaction in Twist Bioscience Corp (TWST). Other recent insider transactions involving Twist Bioscience Corp (TWST) include a net sale of 8,909 shares made by Dennis Cho , a net sale of 55,153 shares made by Emily M. Leproust , and a net sale of 15,708 shares made by Paula Green .

In summary, during the past 3 months, insiders sold 79,841 shares of Twist Bioscience Corp (TWST) in total and bought 0 shares, with a net sale of 79,841 shares. During the past 18 months, 127,742 shares of Twist Bioscience Corp (TWST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 127,742 shares.

Twist Bioscience Corp (TWST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Viii Overage, L.p. made no insider transaction in Unity Biotechnology Inc (UBX). Other recent insider transactions involving Unity Biotechnology Inc (UBX) include a net sale of 10,382 shares made by Anirvan Ghosh , a net sale of 599 shares made by Lynne Marie Sullivan , and a net sale of 381 shares made by Alexander Hieu Nguyen .

In summary, during the past 3 months, insiders sold 717 shares of Unity Biotechnology Inc (UBX) in total and bought 0 shares, with a net sale of 717 shares. During the past 18 months, 11,362 shares of Unity Biotechnology Inc (UBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,362 shares.

Unity Biotechnology Inc (UBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Viii Overage, L.p. made no insider transaction in Quanterix Corp (QTRX). Other recent insider transactions involving Quanterix Corp (QTRX) include a net sale of 5,500 shares made by Laurie J Olson , a net purchase of 47,000 shares made by David R Walt , and a net purchase of 20,200 shares made by William P Donnelly .

In summary, during the past 3 months, insiders sold 0 shares of Quanterix Corp (QTRX) in total and bought 47,000 shares, with a net purchase of 47,000 shares. During the past 18 months, 5,500 shares of Quanterix Corp (QTRX) were sold and 86,200 shares were bought by its insiders, resulting in a net purchase of 80,700 shares.

Quanterix Corp (QTRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Viii Overage, L.p. made no insider transaction in Neumora Therapeutics Inc (NMRA). Other recent insider transactions involving Neumora Therapeutics Inc (NMRA) include a net purchase of 2,007,064 shares made by Kristina Burow , a net purchase of 507,064 shares made by Arch Venture Partners Xii, Llc , and a net sale of 88,235 shares made by Robert A. Lenz .

In summary, during the past 3 months, insiders sold 210,023 shares of Neumora Therapeutics Inc (NMRA) in total and bought 0 shares, with a net sale of 210,023 shares. During the past 18 months, 210,023 shares of Neumora Therapeutics Inc (NMRA) were sold and 7,293,833 shares were bought by its insiders, resulting in a net purchase of 7,083,810 shares.

Neumora Therapeutics Inc (NMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.